Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evelo Biosciences Inc EVLO

Healthcare Biotechnology
Evelo Biosciences, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing a class of oral medicines that act on immune cells in the small intestine with systemic effects. It has built a platform to discover and develop oral medicines, which target the small intestinal axis (SINTAX). Its product candidates are pharmaceutical preparations of single... see more

Recent & Breaking News (GREY:EVLO)

Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis

GlobeNewswire October 17, 2023

Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights

GlobeNewswire August 14, 2023

Evelo Biosciences Closes $25.5 Million Private Placement

GlobeNewswire July 12, 2023

Evelo Biosciences Announces $25.5 Million Private Placement

GlobeNewswire July 10, 2023

Evelo Biosciences Announces Reverse Stock Split Effective

GlobeNewswire June 29, 2023

Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry

PR Newswire May 16, 2023

Evelo Biosciences Provides Clinical Updates

GlobeNewswire April 26, 2023

Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

GlobeNewswire March 16, 2023

Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

GlobeNewswire March 9, 2023

Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference

GlobeNewswire March 1, 2023

Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial

GlobeNewswire February 27, 2023

Evelo Biosciences Provides Clinical and Business Updates

GlobeNewswire February 1, 2023

Horizon Technology Finance Provides Fourth Quarter 2022 Portfolio Update

PR Newswire January 11, 2023

Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt

GlobeNewswire December 16, 2022

Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology

GlobeNewswire November 15, 2022

Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights

GlobeNewswire November 14, 2022

Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference

GlobeNewswire November 8, 2022

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Evelo Biosciences, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire November 7, 2022

Evelo Biosciences Presents Biomarker Data Demonstrating Anti-inflammatory Effects of EDP1815 in Psoriasis at the 2022 European Academy of Dermatology and Venereology (EADV) Congress

GlobeNewswire September 7, 2022

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Evelo Biosciences, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

PR Newswire September 6, 2022